Human chorionic gonadotropin patterns after a single dose of methotrexate for ectopic pregnancy

Andrea Natale, Mauro Busacca, Massimo Candiani, Luciano Gruft, Stefano Izzo, Irene Felicetta, Mario Vignali

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Objective: The great variability in human chorionic gonadotropin (HCG) levels after a single dose of methotrexate (MTX) for ectopic pregnancy makes it difficult to predict treatment failure. We describe different patterns of HCG levels. Study design: Fifty patients were injected i.m. with 50 mg/m2 of MTX for an ectopic pregnancy. Venous blood samples for HCG detection were obtained on the day of treatment (day 0), day 3 and day 7 and weekly until values were undetectable. Patients were classified as: group 1, persistent pathology (n = 11); group 2, complete resolution with a decrease of HCG levels at day 3 (n = 30); group 3, complete resolution after a rise of HCG values at day 3 (n = 9). Statistical analysis was performed using the Mann-Whitney non-parametric test with 95% confidence intervals. Results: Values of day 0 were similar for all the groups. HCG levels of group 3 decreased rapidly after day 3 and at day 7 they were significantly different from levels of group 1. Differences in HCG levels between groups 2 and 3 became indistinguishable from day 21. Conclusion: The observation of patients undergoing resolution after an initial increase of HCG levels justify an expectant management for 1 week in clinically stable patients. The strategy to separate HCG curves in patients undergoing resolution may shed light on the different clinical responses to therapy for ectopic pregnancies. However, the phenomenon of the immediate rise of HCG should be better investigated.

Original languageEnglish
Pages (from-to)227-230
Number of pages4
JournalEuropean Journal of Obstetrics and Gynecology and Reproductive Biology
Volume100
Issue number2
DOIs
Publication statusPublished - Jan 10 2002

Fingerprint

Ectopic Pregnancy
Chorionic Gonadotropin
Methotrexate
Treatment Failure
Observation
Confidence Intervals
Pathology

Keywords

  • Ectopic pregnancy
  • HCG
  • Methotrexate

ASJC Scopus subject areas

  • Obstetrics and Gynaecology
  • Reproductive Medicine

Cite this

Human chorionic gonadotropin patterns after a single dose of methotrexate for ectopic pregnancy. / Natale, Andrea; Busacca, Mauro; Candiani, Massimo; Gruft, Luciano; Izzo, Stefano; Felicetta, Irene; Vignali, Mario.

In: European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 100, No. 2, 10.01.2002, p. 227-230.

Research output: Contribution to journalArticle

Natale, Andrea ; Busacca, Mauro ; Candiani, Massimo ; Gruft, Luciano ; Izzo, Stefano ; Felicetta, Irene ; Vignali, Mario. / Human chorionic gonadotropin patterns after a single dose of methotrexate for ectopic pregnancy. In: European Journal of Obstetrics and Gynecology and Reproductive Biology. 2002 ; Vol. 100, No. 2. pp. 227-230.
@article{20ea9d01164c47b6901d9f290a50900b,
title = "Human chorionic gonadotropin patterns after a single dose of methotrexate for ectopic pregnancy",
abstract = "Objective: The great variability in human chorionic gonadotropin (HCG) levels after a single dose of methotrexate (MTX) for ectopic pregnancy makes it difficult to predict treatment failure. We describe different patterns of HCG levels. Study design: Fifty patients were injected i.m. with 50 mg/m2 of MTX for an ectopic pregnancy. Venous blood samples for HCG detection were obtained on the day of treatment (day 0), day 3 and day 7 and weekly until values were undetectable. Patients were classified as: group 1, persistent pathology (n = 11); group 2, complete resolution with a decrease of HCG levels at day 3 (n = 30); group 3, complete resolution after a rise of HCG values at day 3 (n = 9). Statistical analysis was performed using the Mann-Whitney non-parametric test with 95{\%} confidence intervals. Results: Values of day 0 were similar for all the groups. HCG levels of group 3 decreased rapidly after day 3 and at day 7 they were significantly different from levels of group 1. Differences in HCG levels between groups 2 and 3 became indistinguishable from day 21. Conclusion: The observation of patients undergoing resolution after an initial increase of HCG levels justify an expectant management for 1 week in clinically stable patients. The strategy to separate HCG curves in patients undergoing resolution may shed light on the different clinical responses to therapy for ectopic pregnancies. However, the phenomenon of the immediate rise of HCG should be better investigated.",
keywords = "Ectopic pregnancy, HCG, Methotrexate",
author = "Andrea Natale and Mauro Busacca and Massimo Candiani and Luciano Gruft and Stefano Izzo and Irene Felicetta and Mario Vignali",
year = "2002",
month = "1",
day = "10",
doi = "10.1016/S0301-2115(01)00480-8",
language = "English",
volume = "100",
pages = "227--230",
journal = "European Journal of Obstetrics, Gynecology and Reproductive Biology",
issn = "0028-2243",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

TY - JOUR

T1 - Human chorionic gonadotropin patterns after a single dose of methotrexate for ectopic pregnancy

AU - Natale, Andrea

AU - Busacca, Mauro

AU - Candiani, Massimo

AU - Gruft, Luciano

AU - Izzo, Stefano

AU - Felicetta, Irene

AU - Vignali, Mario

PY - 2002/1/10

Y1 - 2002/1/10

N2 - Objective: The great variability in human chorionic gonadotropin (HCG) levels after a single dose of methotrexate (MTX) for ectopic pregnancy makes it difficult to predict treatment failure. We describe different patterns of HCG levels. Study design: Fifty patients were injected i.m. with 50 mg/m2 of MTX for an ectopic pregnancy. Venous blood samples for HCG detection were obtained on the day of treatment (day 0), day 3 and day 7 and weekly until values were undetectable. Patients were classified as: group 1, persistent pathology (n = 11); group 2, complete resolution with a decrease of HCG levels at day 3 (n = 30); group 3, complete resolution after a rise of HCG values at day 3 (n = 9). Statistical analysis was performed using the Mann-Whitney non-parametric test with 95% confidence intervals. Results: Values of day 0 were similar for all the groups. HCG levels of group 3 decreased rapidly after day 3 and at day 7 they were significantly different from levels of group 1. Differences in HCG levels between groups 2 and 3 became indistinguishable from day 21. Conclusion: The observation of patients undergoing resolution after an initial increase of HCG levels justify an expectant management for 1 week in clinically stable patients. The strategy to separate HCG curves in patients undergoing resolution may shed light on the different clinical responses to therapy for ectopic pregnancies. However, the phenomenon of the immediate rise of HCG should be better investigated.

AB - Objective: The great variability in human chorionic gonadotropin (HCG) levels after a single dose of methotrexate (MTX) for ectopic pregnancy makes it difficult to predict treatment failure. We describe different patterns of HCG levels. Study design: Fifty patients were injected i.m. with 50 mg/m2 of MTX for an ectopic pregnancy. Venous blood samples for HCG detection were obtained on the day of treatment (day 0), day 3 and day 7 and weekly until values were undetectable. Patients were classified as: group 1, persistent pathology (n = 11); group 2, complete resolution with a decrease of HCG levels at day 3 (n = 30); group 3, complete resolution after a rise of HCG values at day 3 (n = 9). Statistical analysis was performed using the Mann-Whitney non-parametric test with 95% confidence intervals. Results: Values of day 0 were similar for all the groups. HCG levels of group 3 decreased rapidly after day 3 and at day 7 they were significantly different from levels of group 1. Differences in HCG levels between groups 2 and 3 became indistinguishable from day 21. Conclusion: The observation of patients undergoing resolution after an initial increase of HCG levels justify an expectant management for 1 week in clinically stable patients. The strategy to separate HCG curves in patients undergoing resolution may shed light on the different clinical responses to therapy for ectopic pregnancies. However, the phenomenon of the immediate rise of HCG should be better investigated.

KW - Ectopic pregnancy

KW - HCG

KW - Methotrexate

UR - http://www.scopus.com/inward/record.url?scp=0037049962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037049962&partnerID=8YFLogxK

U2 - 10.1016/S0301-2115(01)00480-8

DO - 10.1016/S0301-2115(01)00480-8

M3 - Article

VL - 100

SP - 227

EP - 230

JO - European Journal of Obstetrics, Gynecology and Reproductive Biology

JF - European Journal of Obstetrics, Gynecology and Reproductive Biology

SN - 0028-2243

IS - 2

ER -